Clinical Trial Update: Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) [Phase 3]

View source ↗

Summary

Phase 3 study comparing sitagliptin to glipizide in adults with type 2 diabetes and chronic kidney disease has completed; trial results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucotrol (glipizide)
• Januvia (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2012-03-28